More Research Urged to Compare and Validate Genomic Tests in Oncology - ESMO Press Commentary
The European Society for Medical Oncology (ESMO) has welcomed preliminary clinical trial results that suggest genomic testing could allow many patients with early breast cancer to safely avoid chemotherapy.